Pimozide
SIGMA/P1793
Synonym: 1-
CAS Number: 2062-78-4
Empirical Formula (Hill Notation): C28H29F2N3O
Molecular Weight: 461.55
EC Number: 218-171-7
MDL Number: MFCD00055081
Linear Formula: C28H29F2N3O
Product Type: Chemical
| form | powder |
| InChI | 1S/C28H29F2N3O/c29-22-11- |
| InChI key | YVUQSNJEYSNKRX-UHFFFAOYSA |
| originator | Teva |
| Quality Level | 200 ![]() |
| SMILES string | Fc1ccc(cc1)C(CCCN2CCC(CC2 |
| solubility | chloroform: 5 mg/mL |
| DMSO: 18 mg/mL(lit.) | |
| H2O: insoluble(lit.) | |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | D2 dopamine receptor antagonist; binds with high affinity to the cloned 5-HT7 receptor; Ca2+ channel antagonist; antipsychotic |
| Features and Benefits: | This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the Cyclic Nucleotide-Gated (CNG) and Hyperpolarization Activated Cyclic Nucleotide-Gated (HCN) Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Teva . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 1 g in glass bottle |
| Packaging: | 500 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


